ARRAY BIOPHARMA
  
 
Investor Relations Home  |   News   |   Events & Webcasts  |   SEC Filings & Reports  |   Stock Info  |   Analyst Coverage  |   Fundamentals  |   Earnings Estimates  |   FAQs  |   Information Request  |   Financial Tearsheet  |   Corporate Governance
 

Webcast ImageWebcast - Replay
Array BioPharma Inc. at Bank of America Merrill Lynch Health Care Conference
05/16/13 at 11:20 p.m. PT
Receive E-mail AlertsE-mail Alerts
RSS Feeds RSS
Keyword Search
 
2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006
 
12/23/08Array BioPharma Receives $40 Million from DeerfieldPrinter Friendly Version
12/16/08Array BioPharma to Present at the JP Morgan 27th Annual Healthcare ConferencePrinter Friendly Version
11/20/08Array BioPharma to Present at the Piper Jaffray Health Care ConferencePrinter Friendly Version
11/07/08Array BioPharma Inc. Files Shelf Registration StatementPrinter Friendly Version
11/03/08Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2009Printer Friendly Version
10/27/08Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2009 on November 3, 2008Printer Friendly Version
10/26/08Array BioPharma's Oral p38 Inhibitor Demonstrates Significant Analgesic Benefit and Systemic Anti-Inflammatory ActivityPrinter Friendly Version
10/20/08Array BioPharma to Present Clinical Data at the 2008 ACR/ARHP Annual Scientific MeetingPrinter Friendly Version
09/29/08Array BioPharma to Present at the William Blair Small-Cap Growth Stock ConferencePrinter Friendly Version
09/25/08Array BioPharma Presents Positive Preclinical Data on Its Glucokinase Activators in Type 2 DiabetesPrinter Friendly Version
09/16/08Array BioPharma to Present at the UBS Global Life Sciences ConferencePrinter Friendly Version
09/02/08Array BioPharma to Present at the Morgan Stanley Global Healthcare Unplugged Conference and the Baird Small Cap Healthcare ConferencePrinter Friendly Version
08/27/08Array BioPharma to Present at the Thomas Weisel Partners 2008 Healthcare ConferencePrinter Friendly Version
08/11/08Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2008Printer Friendly Version
07/30/08Array BioPharma to Present at the Bank of America 2008 Specialty Pharmaceuticals ConferencePrinter Friendly Version
07/28/08Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2008 on August 11, 2008Printer Friendly Version
06/30/08Array BioPharma to Present at the Collins Stewart 4th Annual Growth ConferencePrinter Friendly Version
06/16/08Array BioPharma to Present at the Jefferies 2nd Annual Healthcare ConferencePrinter Friendly Version
06/12/08Array BioPharma Presents Additional Positive Phase 1 Results in Two Programs at the 2008 Annual European Congress of RheumatologyPrinter Friendly Version
06/10/08Array BioPharma to Present Clinical Data at the 2008 Annual European Congress of RheumatologyPrinter Friendly Version
06/09/08Array BioPharma to Present at the Jefferies 2nd Annual Healthcare ConferencePrinter Friendly Version
05/16/08Array BioPharma to Present at the Citi 2008 Global Healthcare ConferencePrinter Friendly Version
05/15/08Array BioPharma and AstraZeneca Announce New Phase 2 Development Plans for the Investigational Anti-Cancer Drug AZD6244 (ARRY-886)Printer Friendly Version
05/08/08 Array BioPharma to Present at the Bank of America Securities Healthcare ConferencePrinter Friendly Version
05/07/08Array BioPharma Presents Additional Positive Phase 2 Results in Inflammatory Pain Clinical Trial at the American Pain Society's Annual Scientific MeetingPrinter Friendly Version
05/05/08Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2008Printer Friendly Version
05/05/08Array BioPharma Receives $80 Million Funding CommitmentPrinter Friendly Version
05/05/08Array BioPharma to Present at Leerink Swann ConferencePrinter Friendly Version
04/30/08Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2008 on May 5, 2008Printer Friendly Version
03/25/08Array BioPharma Advances p38 / Tie2 Inhibitor, ARRY-614, into Phase 1 Clinical TrialPrinter Friendly Version
03/18/08Array BioPharma Names Gary M. Clark, Ph.D., Vice President, Biostatistics and Data ManagementPrinter Friendly Version
03/13/08Array BioPharma to Present at the Lehman Brothers Global Healthcare ConferencePrinter Friendly Version
03/03/08Array BioPharma Announces Positive Phase 2 Top-Line Results in Inflammatory Pain Clinical TrialPrinter Friendly Version
03/03/08Array BioPharma to Present at the Susquehanna Healthcare ConferencePrinter Friendly Version
02/06/08Array BioPharma to Present at the 2008 BIO CEO & Investor ConferencePrinter Friendly Version
02/04/08Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2008Printer Friendly Version
01/31/08Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2008 on February 4, 2008Printer Friendly Version
01/03/08Array BioPharma to Present at the 26th Annual JPMorgan Healthcare ConferencePrinter Friendly Version

  Printer friendly version

Stock Quote
ARRY (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$5.89
Change (%) Stock is Up 0.20 (3.51%)
Volume912,437
Data as of 05/17/13 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock chart for: 03NA000000ARRY